Handheld Radiofrequency Spectroscopy for Intraoperative Assessment of Surgical Margins During Breast-Conserving Surgery

This policy addresses handheld radiofrequency spectroscopy (e.g., MarginProbe) for intraoperative assessment of surgical margins during breast‑conserving surgery, used as an adjunct to standard methods to help achieve tumor‑free margins in patients undergoing lumpectomy for localized breast cancer, including DCIS and non‑palpable, image‑localized lesions. Coverage is limited to use on the main ex vivo lumpectomy specimen (not in the cavity or on shavings), histologic examination remains the definitive standard, devices are expected to meet high sensitivity/specificity thresholds, and some payers consider the technology experimental/investigational or subject to member contract and state regulations.

"Intraoperative assessment of surgical margins during breast-conserving surgery for localized breast cancer to help achieve tumor‑free margins."

Sign up to see full coverage criteria, indications, and limitations.